Stay updated on Clinical Trial: Benfotiamine in Alzheimer's Disease
Sign up to get notified when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.

Latest updates to the Clinical Trial: Benfotiamine in Alzheimer's Disease page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations section updated to include New York as a study site (White Plains, NY). Revision: v3.3.3.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedTwo minor textual updates were made: a note about publications being provided voluntarily and a revision tag (Revision: v3.3.2) were added, which do not affect core study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoval of the government funding/operating-status notice from the page. No core study content, eligibility criteria, outcomes, or locations were altered.SummaryDifference0.4%

- Check62 days agoChange DetectedA Study Results section with published trial results and related publications has been added to the page. This includes outcomes and methodologies from the Benfotiamine in Alzheimer’s Disease study.SummaryDifference0.4%

- Check91 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference2%

- Check98 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Benfotiamine in Alzheimer's Disease
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.